+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
Oncolytic Virus - Competitive Landscape, 2022 - Product Thumbnail Image

Oncolytic Virus - Competitive Landscape, 2022

  • Report
  • October 2022
  • 300 Pages
  • Global
From
TIGIT Inhibitors - Competitive Landscape, 2022 - Product Thumbnail Image

TIGIT Inhibitors - Competitive Landscape, 2022

  • Report
  • October 2022
  • 100 Pages
  • Global
From
From
Oncolytic Virus Cancer Therapy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 160 Pages
  • Global
From
Intratumoral Cancer Therapies - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intratumoral Cancer Therapies - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 144 Pages
  • Global
From
From
Cytokine Release Syndrome (CRS) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cytokine Release Syndrome (CRS) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 141 Pages
  • Global
From
Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 116 Pages
  • Global
From
From
Masitinib Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Masitinib Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
PALFORZIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

PALFORZIA Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
Global Endometriosis Pain - Pipeline Insight, 2022 - Product Thumbnail Image

Global Endometriosis Pain - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 60 Pages
  • Global
From
From
ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
From
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more